The KOSPI's AI Surge: Genuine Revival or Just a Semiconductor Squeeze? | July 21, 2026

🚀 The KOSPI's AI Surge: Genuine Revival or Just a Semiconductor Squeeze?

Market data recorded on July 21, 2026.

📊 Today's Top Movers (KOSPI Giants)

Company	Ticker	Change (%)	Status
Samsung C&T	028260.KS	▲ +8.19%	Top Gainer
Samsung Electronics	005930.KS	▲ +6.15%	Top Gainer
SK Hynix	000660.KS	▲ +4.08%	Top Gainer
Samsung SDI	006400.KS	▲ +3.87%	Top Gainer
NAVER	035420.KS	▲ +3.82%	Top Gainer
KT Corp	030200.KS	▼ -1.50%	Top Loser
LG Chem	051910.KS	▼ -0.99%	Top Loser
LG Uplus	032640.KS	▼ -0.69%	Top Loser
KT&G	033780.KS	▼ -0.67%	Top Loser
Celltrion	068270.KS	▼ -0.58%	Top Loser

---

1. 📡 Dispatch from the Seoul Trading Desk

Stepping onto the trading floor in Seoul this morning, the air crackled with a familiar energy – a mix of cautious optimism and the underlying buzz of capital flowing. The KOSPI has been on a wild ride, and today's movements, particularly among our tech behemoths, tell a compelling story about where we stand. I've been actively navigating this market for years, and what I see is a fascinating interplay between global macro forces and the distinct, sometimes quirky, dynamics of the Korean economy. We've seen significant foreign institutional selling for much of the year, driven by profit-taking after the initial surge in large-cap tech and broader macro concerns like rising oil prices and a strengthening dollar.

However, today felt different. The bargain hunting from foreign and institutional players was palpable, especially as the index dipped towards the 6,500 mark earlier this week. This isn't just a fleeting moment; it speaks to a deeper conviction, albeit a short-term one, that Korean equities, particularly in the semiconductor space, have been oversold. The government here has been aggressively pushing a narrative of a resurgent economy, even revising its 2026 growth outlook to 3.0%, a five-year high, largely on the back of the semiconductor export boom. While I appreciate the bullish sentiment, my experience tells me that sustained growth requires more than just one booming sector, and domestic consumption remains a concern. Many local economists are still eyeing a more conservative 2.6% growth rate.

The global AI infrastructure buildout is undeniably a powerful tailwind for our chipmakers, propelling exports to unprecedented levels. South Korea's outbound shipments jumped 70.9% year-on-year in June, topping $100 billion for the first time in history, with semiconductor exports skyrocketing 199.5% to an all-time high of $44.82 billion. This export engine is certainly firing on all cylinders. Yet, the real question I always ask myself, as a local investor with my own money on the line, is whether this robust external demand is truly translating into fundamental strength across the board, or if we're simply riding a wave that could crest and break if global sentiment shifts or supply catches up faster than anticipated. Citi, for one, believes the KOSPI is at a record-low valuation and sees more than 50% upside, driven by memory sector fundamentals and market-friendly policies.

2. The High Flyers - Genuine Innovation or Hype?

Today's top gainers are a who's who of Korean tech and industrial powerhouses: Samsung C&T, Samsung Electronics, SK Hynix, Samsung SDI, and NAVER. It's a familiar sight, these names dominating the green side of the ledger. The common thread today, particularly for the Samsung group affiliates and SK Hynix, is the insatiable global demand for semiconductors, especially high-bandwidth memory (HBM) chips crucial for AI. This isn't just hype; it's a fundamental shift in computing that is creating immense demand for specialized memory, and Korea is at the epicenter of this revolution. I believe many of these companies are not just riding a wave but are fundamentally well-positioned to capitalize on this long-term trend.

Let's take a deep dive into Samsung Electronics (005930.KS), which surged over 6% today. As an active investor based in Seoul, I've watched Samsung navigate countless cycles, from feature phones to smartphones, from commodity memory to the cutting edge of foundry technology. What truly excites me about Samsung today isn't just the sheer scale of its operations, but its strategic pivot and execution in the high-growth areas of AI and advanced semiconductors. The company just announced mind-boggling Q2 2026 earnings estimates, expecting an operating profit of around KRW 89.4 trillion ($58.56 billion), an astonishing 1,811% year-over-year increase. This incredible growth is being driven by record-high sales and sharp price increases for DRAM, HBM, and NAND flash chips.

Samsung's business moat in semiconductors is multi-layered. Firstly, it possesses unparalleled scale and integrated manufacturing capabilities. Unlike many competitors, Samsung operates across the entire semiconductor value chain, from design to foundry to memory production. This allows for tighter control over quality, supply, and innovation. Secondly, its recent success in HBM, specifically the HBM4E samples now shipping to global customers, marks a significant catch-up against competitors like SK Hynix, which had an early lead. This competitive sprint for HBM dominance is crucial, as these chips are the lifeblood of AI accelerators. Samsung's ability to not only produce but also rapidly innovate in this space gives it a formidable edge. We've also seen reports of Samsung Foundry returning to monthly profitability in June 2026 for the first time in three years, and securing a $16.5 billion contract from Tesla to manufacture AI chips, with talks ongoing for similar orders from Anthropic and Meta. This demonstrates a broadening of its semiconductor prowess beyond just memory.

Beyond semiconductors, Samsung C&T (028260.KS), the de facto holding company of the Samsung Group, gained over 8%. Its diversified portfolio, including construction, trading, and investments, often acts as a proxy for the broader Samsung ecosystem's health. When Samsung Electronics flourishes, C&T tends to follow, reflecting the conglomerate's overall strength and future growth prospects. Samsung SDI (006400.KS) also saw a respectable gain of almost 4%. While the EV battery market has faced headwinds, SDI's focus on premium EV batteries and its burgeoning energy storage system (ESS) business, bolstered by U.S. tax credits (AMPC) and improving demand for UPS batteries for AI data centers, is starting to bear fruit. Analysts are predicting a return to profitability for Samsung SDI in Q2, primarily driven by these factors, not necessarily a full recovery in the EV segment.

NAVER (035420.KS) also climbed today, suggesting renewed interest in Korea's internet and platform giants. While the AI narrative has largely focused on hardware, the applications layer, where NAVER operates with its search, e-commerce, and content platforms, will undoubtedly be a beneficiary of increased AI capabilities. I see this as a balanced movement, indicating that investors are looking beyond just the immediate semiconductor plays and recognizing the broader ecosystem benefits of the AI revolution for well-established digital platforms.

3. The Bleeding Edge - Broken Theses or Bargain Bins?

On the flip side, we have our laggards: KT Corp, LG Chem, LG Uplus, KT&G, and Celltrion. When I see these names in the red, my first thought isn't panic, but rather an immediate analysis of whether the decline signals a broken business thesis or simply a market overreaction that presents a buying opportunity. In Korea, where institutional biases and short-term narratives can sometimes overshadow long-term value, distinguishing between the two is crucial for sustainable wealth accumulation.

LG Chem (051910.KS), down nearly 1%, is a prime example of a company facing structural challenges. While it's attempting to pivot into high-value semiconductor materials by securing a supply deal for advanced strippers, its core petrochemical business, where it's the largest naphtha cracking center (NCC) operator, is under immense pressure. The company's financial health is eroding as it pours resources into battery and battery materials facilities amid weak profitability. Its Altman Z-Score, a measure of financial distress, has been steadily declining and recently fell below 1, signaling increased risk. This isn't just a temporary blip; it reflects a deeper structural crisis in the petrochemical industry, coupled with the heavy investment required for future battery ventures that aren't yet fully profitable. My portfolio is cautious on LG Chem until I see clear evidence of successful restructuring and a sustained turnaround in its core segments.

The telecom sector, represented by KT Corp (030200.KS) and LG Uplus (032640.KS), saw declines of 1.5% and 0.69% respectively. These are typically defensive stocks, but they are contending with market saturation and intense competition. While LG Uplus is making strides in partnering with Ericsson on network-based voice AI solutions and winning major public Wi-Fi deals, it also recently lost a lawsuit over exaggerating 5G speeds in advertisements, incurring a penalty. KT, as the largest telecom provider, faces similar headwinds. The growth outlook for these companies remains modest compared to the high-flying tech sector. While they offer stable dividends, significant capital appreciation is often limited unless there's a disruptive innovation or a major regulatory shift. From my perspective, they are more income plays than growth engines for my portfolio, and today's slight dip doesn't fundamentally alter that thesis.

Celltrion (068270.KS), a biosimilar giant, saw a modest drop of 0.58%. This is interesting because Celltrion recently reported record-high Q2 2026 performance, with revenue up 35.2% year-on-year and operating profit surging 77.3%, driven by high-margin newer biosimilar products. The company is expanding its portfolio and is also progressing with novel drug development. However, the biosimilar industry is evolving. Regulatory bodies in the U.S. and Europe are moving towards waiving Phase 3 clinical trials for biosimilars, shifting the focus from development speed to commercialization prowess. This change, while potentially beneficial for large players like Celltrion with established manufacturing and sales networks, also intensifies competition. So, while the fundamentals appear strong, the market might be digesting the implications of this evolving competitive landscape. For me, Celltrion remains a compelling long-term hold given its pipeline and market share gains, and today's small dip could be a transient reaction to broader market sentiment rather than a reflection of deteriorating company health.

Lastly, KT&G (033780.KS), a tobacco and ginseng conglomerate, was down slightly. The tobacco industry globally faces increasing regulatory scrutiny and declining traditional cigarette consumption. While KT&G has been expanding its next-generation product (NGP) portfolio and exploring international partnerships, South Korean regulations are also tightening, requiring disclosure of harmful substances. Despite strong Q2 earnings projections driven by international sales and NGP growth, the long-term structural headwinds for tobacco remain. My wealth accumulation strategy prefers sectors with clearer growth runways, so KT&G typically stays on my watchlist rather than in my core portfolio.

4. Strategic Portfolio Allocation

Today's KOSPI movements reinforce my conviction in the structural tailwinds benefiting the Korean semiconductor industry, particularly those companies at the forefront of AI memory. Samsung Electronics and SK Hynix, despite their volatility, represent a genuine innovation cycle that is far from over. I continue to allocate a significant portion of my capital to these leaders, recognizing that their global competitiveness and technological moats are substantial. I see the current market corrections, like the recent dip, as opportunities to accumulate more of these high-quality assets at more favorable valuations, rather than signaling a permanent shift in their fortunes. The long-term demand for AI infrastructure is a powerful force, and these companies are simply indispensable to that future. My portfolio will maintain its overweight position in this sector, targeting quality names with strong balance sheets and proven innovation capabilities.

For the laggards, my approach remains selective. I am wary of businesses facing deep structural issues, like LG Chem's petrochemical segment, and prefer to wait for clearer signs of a sustainable turnaround. For defensive plays like the telcos, they serve a purpose for stability and income, but they aren't where I expect significant growth. Celltrion, on the other hand, presents an interesting case where strong fundamentals are meeting an evolving regulatory landscape. I hold onto my positions there, confident in its long-term growth trajectory in biosimilars. In essence, my strategy continues to be about discerning genuine, sustainable growth driven by fundamental shifts, and patiently acquiring those assets when the market offers them at a discount, rather than chasing every fleeting trend.